Scholarlink

Background <p>Diagnosing AFP-negative hepatocellular carcinoma (HCC) is challenging. Autoantibodies to tumor-associated antigens have been extensively investigated as serum biomarkers.</p> Methods <p>We employed serological proteome analysis and protein microarray to identify potential autoantibodies for HCC, followed by a two-center and two-independent-phase validation and evaluation using ELISA in patients with AFP-negative HCC (ANHCC). LASSO regression addressed multicollinearity among biomarkers. Four machine-learning methods developed diagnostic models for ANHCC. ROC analysis and various evaluation indicators were applied to assess the performance.</p> Results <p>Eight autoantibodies out of sixteen candidates, including Survivin, NPM1, GNAS, SRSF2, GNA11, PTCH1, GAPDH, and HSP90, were validated as superior biomarkers. The Logistic regression model was optimal for ANHCC, achieving an area under the ROC (AUC) of 0.883 in the training dataset and an AUC of 0.840 in the validation dataset. When tested on the entire HCC patient cohort, which included both ANHCC and AFP-positive patients (APHCC), with ANHCC accounting for 37.5%, the AUC reached 0.825, with a sensitivity of 66.4%, and a specificity of 84.2%. Combining this model with AFP improved efficacy, yielding an AUC of 0.945, an IDI of 23.1%, and an NRI of 21.1% compared to using AFP alone.</p> Conclusion <p>The Logistic regression model demonstrates superior diagnostic performance for ANHCC. Integrating this model with AFP enhances the entire HCC diagnosis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A nomogram based on autoantibodies for noninvasive detection of AFP-negative hepatocellular carcinoma: a multicenter study

  • 期刊论文

  • 发表日期：

    2025年10月2日

查看全文
  • Keyan Wang,
  • Wenzhuo Xiong,
  • Xuehui Duan,
  • Qing Li,
  • Pengfei Ren,
  • Hua Ye,
  • Jingjing Liu,
  • Renle Du,
  • Jianxiang Shi,
  • Peng Wang,
  • Liping Dai

摘要

Background

Diagnosing AFP-negative hepatocellular carcinoma (HCC) is challenging. Autoantibodies to tumor-associated antigens have been extensively investigated as serum biomarkers.

Methods

We employed serological proteome analysis and protein microarray to identify potential autoantibodies for HCC, followed by a two-center and two-independent-phase validation and evaluation using ELISA in patients with AFP-negative HCC (ANHCC). LASSO regression addressed multicollinearity among biomarkers. Four machine-learning methods developed diagnostic models for ANHCC. ROC analysis and various evaluation indicators were applied to assess the performance.

Results

Eight autoantibodies out of sixteen candidates, including Survivin, NPM1, GNAS, SRSF2, GNA11, PTCH1, GAPDH, and HSP90, were validated as superior biomarkers. The Logistic regression model was optimal for ANHCC, achieving an area under the ROC (AUC) of 0.883 in the training dataset and an AUC of 0.840 in the validation dataset. When tested on the entire HCC patient cohort, which included both ANHCC and AFP-positive patients (APHCC), with ANHCC accounting for 37.5%, the AUC reached 0.825, with a sensitivity of 66.4%, and a specificity of 84.2%. Combining this model with AFP improved efficacy, yielding an AUC of 0.945, an IDI of 23.1%, and an NRI of 21.1% compared to using AFP alone.

Conclusion

The Logistic regression model demonstrates superior diagnostic performance for ANHCC. Integrating this model with AFP enhances the entire HCC diagnosis.